Home

ерозия Павета либри constant ratio drug design nature 2016 перспектива семинар добре

Effective drug combinations in breast, colon and pancreatic cancer cells |  Nature
Effective drug combinations in breast, colon and pancreatic cancer cells | Nature

The emerging role of mass spectrometry-based proteomics in drug discovery |  Nature Reviews Drug Discovery
The emerging role of mass spectrometry-based proteomics in drug discovery | Nature Reviews Drug Discovery

A unified drug–target interaction prediction framework based on knowledge  graph and recommendation system | Nature Communications
A unified drug–target interaction prediction framework based on knowledge graph and recommendation system | Nature Communications

Strategies and challenges for the next generation of antibody–drug  conjugates | Nature Reviews Drug Discovery
Strategies and challenges for the next generation of antibody–drug conjugates | Nature Reviews Drug Discovery

Evaluating drug targets through human loss-of-function genetic variation |  Nature
Evaluating drug targets through human loss-of-function genetic variation | Nature

Design of protein-binding proteins from the target structure alone | Nature
Design of protein-binding proteins from the target structure alone | Nature

A rational blueprint for the design of chemically-controlled protein  switches | Nature Communications
A rational blueprint for the design of chemically-controlled protein switches | Nature Communications

Proteome-wide covalent ligand discovery in native biological systems |  Nature
Proteome-wide covalent ligand discovery in native biological systems | Nature

Improving Drug Candidates by Design: A Focus on Physicochemical Properties  As a Means of Improving Compound Disposition and Safety | Chemical Research  in Toxicology
Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety | Chemical Research in Toxicology

Automating drug discovery | Nature Reviews Drug Discovery
Automating drug discovery | Nature Reviews Drug Discovery

Avidity in antibody effector functions and biotherapeutic drug design |  Nature Reviews Drug Discovery
Avidity in antibody effector functions and biotherapeutic drug design | Nature Reviews Drug Discovery

Engineering precision nanoparticles for drug delivery | Nature Reviews Drug  Discovery
Engineering precision nanoparticles for drug delivery | Nature Reviews Drug Discovery

Exploring protein hotspots by optimized fragment pharmacophores | Nature  Communications
Exploring protein hotspots by optimized fragment pharmacophores | Nature Communications

Predictive validity in drug discovery: what it is, why it matters and how  to improve it | Nature Reviews Drug Discovery
Predictive validity in drug discovery: what it is, why it matters and how to improve it | Nature Reviews Drug Discovery

Immune targets for therapeutic development in depression: towards precision  medicine | Nature Reviews Drug Discovery
Immune targets for therapeutic development in depression: towards precision medicine | Nature Reviews Drug Discovery

The Time and Place for Nature in Drug Discovery | JACS Au
The Time and Place for Nature in Drug Discovery | JACS Au

Counting on natural products for drug design | Nature Chemistry
Counting on natural products for drug design | Nature Chemistry

A machine learning-based chemoproteomic approach to identify drug targets  and binding sites in complex proteomes | Nature Communications
A machine learning-based chemoproteomic approach to identify drug targets and binding sites in complex proteomes | Nature Communications

Massively parallel de novo protein design for targeted therapeutics | Nature
Massively parallel de novo protein design for targeted therapeutics | Nature

Pharmacophore hybridisation and nanoscale assembly to discover  self-delivering lysosomotropic new-chemical entities for cancer therapy |  Nature Communications
Pharmacophore hybridisation and nanoscale assembly to discover self-delivering lysosomotropic new-chemical entities for cancer therapy | Nature Communications

Programmable self-regulated molecular buffers for precise sustained drug  delivery | Nature Communications
Programmable self-regulated molecular buffers for precise sustained drug delivery | Nature Communications

Targeting cancer metabolism in the era of precision oncology | Nature  Reviews Drug Discovery
Targeting cancer metabolism in the era of precision oncology | Nature Reviews Drug Discovery

Bioorthogonal in situ assembly of nanomedicines as drug depots for  extracellular drug delivery | Nature Communications
Bioorthogonal in situ assembly of nanomedicines as drug depots for extracellular drug delivery | Nature Communications

Modulating biomolecular condensates: a novel approach to drug discovery |  Nature Reviews Drug Discovery
Modulating biomolecular condensates: a novel approach to drug discovery | Nature Reviews Drug Discovery

Advances in covalent drug discovery | Nature Reviews Drug Discovery
Advances in covalent drug discovery | Nature Reviews Drug Discovery

New strategy for drug discovery by large-scale association analysis of  molecular networks of different species | Scientific Reports
New strategy for drug discovery by large-scale association analysis of molecular networks of different species | Scientific Reports

Machine learning models to accelerate the design of polymeric long-acting  injectables | Nature Communications
Machine learning models to accelerate the design of polymeric long-acting injectables | Nature Communications